“The US Food and Drug Administration has tentatively approved the first generic version of lenacapavir, a groundbreaking HIV drug that prevents infection with just two yearly injections. Dr. Reddy’s Laboratories, an Indian pharmaceutical company, developed the generic formulation and has pledged to sell it for $40 per person annually. The ‘tentative’ approval means that the drug meets FDA standards but cannot be sold in the United States because of existing patent protections. However, because many foreign regulators rely on the FDA’s assessments of new drugs, the approval should accelerate the drug’s distribution abroad. Under a 2024 licensing agreement with Gilead Sciences, lenacapavir’s original developer, generic versions can be sold in 120 low- and middle-income countries,” reports Human Progress.
Scientists have also engineered a virus to steal proteins from the HIV virus, as a way to potentially fight AIDS.
Read Full Article: https://libertyunyielding.com/2026/11/10/40-a-year-anti-aids-drug/
